IL6 and thrombocytosis disease: Due to the lack of IL-6-associated thrombocytosis and polyclonal hypergammaglobulinemia in iMCD-TAFRO phenotypes, their work has additionally suggested that elevated serum IL-6 may not be a sole pathological driver of hypercytokinemia in patients with iMCD-TAFRO.